Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)

NCT03779711 is registered in ClinicalTrials.gov with Timothy J Nelson, MD, PhD as lead sponsor.

NCT NCT03779711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03779711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)
Lead sponsor
Timothy J Nelson, MD, PhD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 6, 2019
Completion date
February 28, 2026
Enrollment
95 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypoplastic left heart syndrome